tiragolumab,carboplatin,etoposide,atezolizumab
roche
['lung', 'atezolizumab', 'sclc', 'tiragolumab', 'skyscraper-02']
skyscraper-02: primary results of a phase iii, randomized, double-blind, placebo-controlled study of atezolizumab (atezo) + carboplatin + etoposide (ce) with or without tiragolumab (tira) in patients (pts) with untreated extensive-stage small cell lung cancer (es-sclc).
#asco22
??????????????????

J-OSLER??????J-OSLER1???????????????

??????https://t.co/ZcsDggiURy…